|
|
 |
|
Viewing report
|
|
 |
 |
Western European Markets for Percutaneous Coronary Intervention
Frost & Sullivan, Sep 2009, Pages: 236
The objective of this research service is to provide detailed analysis of the largely stable European PCI market. This service provides an in-depth analysis of the market split into six segments - Coronary Stents, coronary catheters, coronary guidewires, angioplasty balloons, balloon inflators and embolic protection devices. The research service discusses revenues, market share analysis and the competitive landscape for each segment. It also provides strategies for companies involved in the PCI market. Additionally, the research service provides decision support databases related to hospital resources and healthcare expenditure.
This Frost & Sullivan research service titled Western European Markets for Percutaneous Coronary Intervention (PCI) Devices provides an in-depth examination of market drivers, market restraints and industry challenges. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: coronary stents, coronary catheters, coronary guidewires, angioplasty balloons, balloon inflators and embolic protection devices.
Market Overview
New Entrants with Advanced Products Set to Make Gains
The highly competitive western European percutaneous coronary intervention (PCI) devices market offers growth potential for entrants providing technologically advanced products. The technology involved in the market for PCI devices is highly complex. In addition, new product launches occur frequently, requiring expert explanation. Such trends are creating solid growth opportunities. “There have been rapid technological advancements, especially in the stent and catheter market sectors,” notes the analyst of this research. “Scientists and entrepreneurs are developing novel technologies that offer significant improvements over current technologies. This, together with strong intellectual property and a comprehensive clinical development plan, is set to attract venture capitalists.”
Reinforcing market prospects is the increasing government focus on cardiovascular disease (CVD) as a public health issue. CVD is the leading cause of premature death in Europe. An ageing baby boomer population and sedentary lifestyles is set to increase the number of CVD patients. At the same time, developments in imaging technology have enhanced the accuracy and safety of cardiac surgery and implantation. This has led to an increase in the number of attempted interventional procedures.
Smaller Companies face Uphill Task
Well-entrenched competitors threaten the viability of smaller companies. “A major concern among new participants is the huge R&D expense that a device company has to incur in order to develop devices, conduct clinical trials, gain approval and market the devices,” explains the analyst. “The spate of high-profile mergers and acquisitions in the market has further weakened the potential for the rapid growth of smaller companies.”
To successfully penetrate the market, companies should forge long-term contracts and relationships with distributors and acute and alternate care facilities. “In order to compete with the larger participants and expand market share, smaller manufacturers need to gain the preference of distributors, hospitals and alternate care facilities,” advises the analyst.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Coronary stents - Coronary catheters - Coronary guidewires - Angioplasty balloons - Balloon inflators - Embolic protection devices
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Interventional Cardiology - Global Strategic Business Report
European Markets for Interventional Cardiology Devices 2011 (15 Countries)
Innovations in Transcatheter Stents and Transcatheter Aortic Valves
Percutaneous Transluminal Coronary Angioplasty (PTCA) Products - Global Strategic Business Report
Global Embolic Protection Devices (EPD) - Market Growth Analysis, 2009-2015
European Markets for Interventional Cardiology 2009 (15 Countries)
European Markets for Interventional Cardiology Devices 2011 (15 Countries) (Executive Summary)
U.S. Market for Interventional Cardiology Devices 2011 (Executive Summary)
European Markets for Peripheral Vascular Devices (15 Countries) (Executive Summary)
Peripheral Vascular & Interventional Cardiology Devices Market (2011 – 2016) (Balloons, Evar Stent Grafts, Ivc Filter, Ivus & Angiography Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Accessory Devices) Global Trends &
|
 |
|
|